Showing results (1-10 of 99) with videos related to
Sort By:
Pageof 10
Experimental Cell Research|March 23, 2011
Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomabDirk Nagorsen, Patrick A BaeuerleCancer Research|June 11, 2009
Bispecific T-cell engaging antibodies for cancer therapyPatrick A Baeuerle, Carsten ReinhardtMolecular Immunology|June 9, 2004
A bispecific single-chain antibody fusion protein for targeted depletion of autoreactive B cells via unstimulated human T lymphocytesMarcel Zocher, Patrick A BaeuerleCurrent Opinion in Oncology|July 26, 2022
T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunitiesPatrick A Baeuerle, Holger WescheCurrent Pharmaceutical Biotechnology|September 20, 2012
Clinical experience with gene therapy and bispecific antibodies for T cell-based therapy of cancerPatrick A Baeuerle, Christian ItinThe Journal of Experimental Medicine|April 8, 2024
CD19-directed T cell-engaging antibodies for the treatment of autoimmune diseaseJennifer S Michaelson, Patrick A BaeuerleChemistry & Biology|September 20, 2014
Human therapies as a successful liaison between chemistry and biologyPatrick A Baeuerle, Jerry A MurryCurrent Opinion in Chemical Biology|April 30, 2013
Targeting T cells to tumor cells using bispecific antibodiesStanley R Frankel, Patrick A BaeuerleCurrent Opinion in Molecular Therapeutics|January 27, 2009
BiTE: Teaching antibodies to engage T-cells for cancer therapyPatrick A Baeuerle, Peter Kufer, Ralf BargouCancer Research|July 9, 2009
The emerging role of EpCAM in cancer and stem cell signalingMarkus Munz, Patrick A Baeuerle, Olivier GiresPageof 10